株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の体外診断 (IVD) 市場

Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook 2016-2020

発行 Koncept Analytics 商品コード 223486
出版日 ページ情報 英文 81 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.33円で換算しております。
Back to Top
世界の体外診断 (IVD) 市場 Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook 2016-2020
出版日: 2016年12月07日 ページ情報: 英文 81 Pages
概要

当レポートでは、世界における体外診断 (IVD) 市場の発展動向を分析しており、市場の成長促進要因と課題、地域別市場の主な動向、主要企業の市場シェア/プロファイルなどを提供しています。

第1章 概要

  • IVD製品の種類
  • IVD検査
  • 技術別のIVD市場
  • IVDの利用
  • IVDのバリューチェーン分析

第2章 世界のIVD市場

  • 収益
  • 収益予測
  • 地域別市場
  • 製品タイプ別市場
  • 検査ロケーション別市場
  • 技術別市場

第3章 世界のIVD市場:技術別

  • 血糖自己測定 (SMBG) 市場の収益予測
  • 臨床化学市場の収益予測
  • 免疫化学市場
  • 分子診断市場
  • ポイントオブケア (POC) 市場の収益予測
  • 微生物学市場の収益予測
  • 血液学市場の収益予測

第4章 IVDの地域別市場

  • 北米
  • 欧州・中東・アフリカ地域
  • アジア太平洋地域
  • ラテンアメリカ

第5章 市場力学

  • 成長促進要因
  • 主要動向
  • 課題

第6章 競合情勢

  • IVD市場におけるシェア
  • 免疫化学市場におけるシェア
  • 分子診断市場におけるシェア
  • POCT市場におけるシェア
  • 臨床化学市場におけるシェア

第7章 企業プロファイル

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Diagnosis is the identification of the nature and cause of a certain phenomenon. It involves two different types of testing method: in vivo and in vitro diagnostics. In-vitro diagnostics (IVDs) tests are defined as tests executed outside a patient's body which put analytical instruments, devices, reagents, calibrators and systems to use for checking of health status or diagnosing diseases. In-vitro means 'in the glass', as traditionally these tests were directed in glass test tubes. On the other hand, in-vivo diagnostics tests like electroencephalography, electrocardiography and imaging are executed inside a patient's body.

The global IVD market is segmented on the basis of product, technology used and test location. On the basis of product, this market can be divided into three sub segments; Reagents, analytical instruments and accessory products. By technologies employed, it can be segmented into seven sub segments; immunochemistry, SMBG, POCT, molecular diagnostics, clinical chemistry, microbiology, hematology and others. Further, depending upon test location, the market can be divided into three sub segments; labs, POC and self-test.

Growth of the global IVD market is driven by several factors including rising cases of infectious disease, increasing diabetic patient base, increasing number of patients suffering from chronic ailments such as cancer. Additionally, escalating global aged population, rising GDP per capita and increasing healthcare expenditure per capita will act as a catalyst for market growth. Owing to the suitable demographical changes and rising disposable income coupled with improving basic infrastructure, developing regions such as Asia-Pacific and Latin America are expected to experience robust growth. However, the market growth is hindered by lack of customer adoption, unclear regulation of new advancing technologies and lack of basic facilities and infrastructure.

The report "Global IVD Market: Industry Analysis & Outlook (2016-2020)" analyzes the development of this market, with focus on the North America, EMEA, Asia-Pacific and Latin America markets. The major trends, growth drivers as well as issues faced by the market are discussed in detail in this report. The four major players: Siemens AG., Inc., Roche Holdings AG., Abbott Laboratories and Danaher Corp. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global IVD market along with the study of the regional markets.

Table of Contents

1. Overview

  • 1.1 In-Vitro Diagnostics (IVD)
  • 1.2 IVD Product by Types
  • 1.3 IVD Tests
  • 1.4 IVD Market by Technology
  • 1.5 IVD Uses
  • 1.6 IVD Value Chain Analysis

2. Global IVD Market

  • 2.1 Global IVD Market by Value
  • 2.2 Global IVD Market Forecast by Value
  • 2.3 Global IVD Market by Region
  • 2.4 Global IVD Market by Product Type
  • 2.4.1 Global IVD Reagents Market Forecast by Value
  • 2.5 Global IVD Market by Test Location
  • 2.6 Global IVD Market by Technology

3. Global IVD Market Analysis by Technology

  • 3.1 Global SMBG Market Forecast by Value
  • 3.2 Global Clinical Chemistry Market Forecast by Value
  • 3.3 Global Immunochemistry Market
    • 3.3.1 Global Immunochemistry Market Forecast by Value
    • 3.3.2 Global Immunochemistry Market by Applications
  • 3.4 Global Molecular Diagnostics Market
    • 3.4.1 Global Molecular Diagnostics Market by Value
    • 3.4.2 Global Molecular Diagnostics Market by Applications
  • 3.5 Global Point Of Care (POC) Market Forecast by Value
  • 3.6 Global Microbiology Market Forecast by Value
  • 3.7 Global Hematology Market Forecast by Value

4. Regional IVD Market

  • 4.1 North-America
    • 4.1.1 The North-America IVD Market Forecast by Value
  • 4.2 EMEA
    • 4.2.1 EMEA IVD Market Forecast by Value
  • 4.3 Asia-Pacific
    • 4.3.1 Asia-Pacific IVD Market Forecast by Value
    • 4.3.2 China IVD Market Forecast by Value
    • 4.3.3 Japan IVD Market Forecast by Value
  • 4.4 Latin America
    • 4.4.1 Latin America IVD Market Forecast by Value

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Increasing Diabetic Patient Base
    • 5.1.2 Rapid Occurrence of Infectious Diseases
    • 5.1.3 Surge in Incidences of Chronic Ailments
    • 5.1.4 Increasing Global Healthcare Expenditure Per Capita
    • 5.1.5 Rising Global GDP per Capita
    • 5.1.6 Escalating Aged Population
  • 5.2 Trends
    • 5.2.1 Development and Approval of Effective Companion Diagnostics
    • 5.2.2 Companies Focusing on Multiple Genome Analysis
    • 5.2.3 Increasing Clinical Microbiology Laboratories in Developing Nations
    • 5.2.4 Growing Point Of Care (POC) Segment
  • 5.3 Challenges
    • 5.3.1 Lack of Customer Adoption
    • 5.3.2 Unclear Regulation of New Advancing Technologies
    • 5.3.3 Urgent Need for Proper Infrastructure

6. Competitive Landscape

  • 6.1 Global IVD Market Share by Company
  • 6.2 Global Immunochemistry Market Share by Company
  • 6.3 Global Molecular Diagnostics Market Share by Company
  • 6.4 Global POCT Market Share by Company
  • 6.5 Global Clinical Chemistry Market Position by Company

7. Company Profiles

  • 7.1 Siemens AG.
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 Roche Holding AG
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 Abbott Laboratories
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 Danaher Corp.
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies

List of Charts

  • Types of Diagnostics
  • Types of IVD Products
  • Types of IVD Tests
  • IVD Market by Technology
  • IVD Value Chain Analysis
  • Global IVD Market by Value (2011-2015)
  • Global IVD Market Forecast by Value (2016-2020)
  • Global IVD Market by Region (2015)
  • Global IVD Market by Product Type (2015)
  • Global IVD Reagents Market Forecast by Value (2015-2020)
  • Global IVD Market by Test Location (2015)
  • Global IVD Market by Technology (2015)
  • Global SMBG Market Forecast by Value (2015-2020)
  • Global Clinical Chemistry Market Forecast by Value (2015-2020)
  • Global Immunochemistry Market Forecast by Value (2015-2020)
  • Global Immunochemistry Market by Applications (2015)
  • Global Molecular Diagnostics Market by Value (2015-2020)
  • Global Molecular Diagnostics Market by Applications (2015)
  • Global Point Of Care (POC) Market Forecast by Value (2015-2020)
  • Global Microbiology Market Forecast by Value (2015-2020)
  • Global Hematology Market Forecast by Value (2015-2020)
  • The North-America IVD Market Forecast by Value (2015-2020)
  • EMEA IVD Market Forecast by Value (2015-2020)
  • Asia-Pacific IVD Market Forecast by Value (2015-2020)
  • China IVD Market Forecast by Value (2015-2020)
  • Japan IVD Market Forecast by Value (2015-2020)
  • Latin America IVD Market Forecast by Value (2015-2020)
  • Global Type 2 Diabetes Patients by Volume (2015-2020)
  • Global New Cancer Patients by Volume (2011-2015)
  • Global Healthcare Expenditure Per Capita (2011-2015)
  • Global GDP Per Capita (2011-2015)
  • Global Population above 64 Years (2011-2015)
  • Global IVD Market Share by Company (2015)
  • Global Immunochemistry Market Share by Company (2015)
  • Global Molecular Diagnostics Market by Company (2015)
  • Global POCT Market Share by Company (2015)
  • Siemens AG. Revenue by Segments (2015)
  • Siemens AG. Revenue and Net Income (2011-2015)
  • Siemens AG. R&D Expenditure (2013-2015)
  • Roche Holding AG Revenue by Segment (2015)
  • Roche Holding AG Revenue and Net Income (2011-2015)
  • Roche Holding AG R&D Expenditure (2013-2015)
  • Abbott Laboratories Revenue by Segment (2015)
  • Abbott Laboratories Revenue and Net Income (2011-2015)
  • Abbott Laboratories R&D Expenditure (2013-2015)
  • Danaher Corp. Revenue by Segment (2015)
  • Danaher Corp. Revenue and Net Income (2011-2015)
  • Danaher Corp. R&D Expenditure (2013-2015)

List of Tables

  • Growing Cases and Prevalence of STDs in the US (2008-2015)
  • The US approval for Companion Diagnostic (CD) Reagents
  • Clinical Chemistry Market Position by Players (2015)
Back to Top